Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,421 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Towards the use of cannabinoids as antitumour agents.
Velasco G, Sánchez C, Guzmán M. Velasco G, et al. Among authors: sanchez c. Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247. Nat Rev Cancer. 2012. PMID: 22555283 Review.
New inhibitors of angiogenesis with antitumor activity in vivo.
Marín-Ramos NI, Alonso D, Ortega-Gutiérrez S, Ortega-Nogales FJ, Balabasquer M, Vázquez-Villa H, Andradas C, Blasco-Benito S, Pérez-Gómez E, Canales Á, Jiménez-Barbero J, Marquina A, del Prado JM, Sánchez C, Martín-Fontecha M, López-Rodríguez ML. Marín-Ramos NI, et al. Among authors: sanchez c. J Med Chem. 2015 May 14;58(9):3757-66. doi: 10.1021/jm5019252. Epub 2015 May 4. J Med Chem. 2015. PMID: 25906180
Endocannabinoids and Cancer.
Velasco G, Sánchez C, Guzmán M. Velasco G, et al. Among authors: sanchez c. Handb Exp Pharmacol. 2015;231:449-72. doi: 10.1007/978-3-319-20825-1_16. Handb Exp Pharmacol. 2015. PMID: 26408171 Review.
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C. Moreno E, et al. Among authors: sanchez c. J Biol Chem. 2014 Aug 8;289(32):21960-72. doi: 10.1074/jbc.M114.561761. Epub 2014 Jun 18. J Biol Chem. 2014. PMID: 24942731 Free PMC article.
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C. Blasco-Benito S, et al. Among authors: sanchez c. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3863-3872. doi: 10.1073/pnas.1815034116. Epub 2019 Feb 7. Proc Natl Acad Sci U S A. 2019. PMID: 30733293 Free PMC article.
Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.
Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, García-Taboada E, Wade J, Smith S, Guzmán M, Pérez-Gómez E, Gordon M, Sánchez C. Blasco-Benito S, et al. Among authors: sanchez c. Biochem Pharmacol. 2018 Nov;157:285-293. doi: 10.1016/j.bcp.2018.06.025. Epub 2018 Jun 27. Biochem Pharmacol. 2018. PMID: 29940172
Cannabinoids: a new hope for breast cancer therapy?
Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: sanchez c. Cancer Treat Rev. 2012 Nov;38(7):911-8. doi: 10.1016/j.ctrv.2012.06.005. Epub 2012 Jul 7. Cancer Treat Rev. 2012. PMID: 22776349 Review.
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, Flores JM, García-Real I, Palacios J, Mañes S, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: sanchez c. Mol Cancer. 2010 Jul 22;9:196. doi: 10.1186/1476-4598-9-196. Mol Cancer. 2010. PMID: 20649976 Free PMC article.
Cannabinoids and gliomas.
Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. Velasco G, et al. Among authors: sanchez c. Mol Neurobiol. 2007 Aug;36(1):60-7. doi: 10.1007/s12035-007-0002-5. Epub 2007 Jun 28. Mol Neurobiol. 2007. PMID: 17952650 Review.
2,421 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page